Clemastine fumarate attenuates tauopathy and meliorates cognition in hTau mice via autophagy enhancement
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110649 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Jiahui Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Ne…. Hauptthemen laut MEDLINE: Alzheimer Disease, Tauopathies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Clemastine fumarate, which has been identified as a promising agent for remyelination and autophagy enhancement, has been shown to mitigate Aβ deposition and improve cognitive function in the APP/PS1 mouse model of Alzheimer's disease. Based on these findings, we investigated the effect of clemastine fumarate in hTau mice, a different Alzheimer's disease model characterized by overexpression of human Tau protein. Surprisingly, clemastine fumarate was effective in reducing pathological deposition of Tau protein, protecting neurons and synapses from damage, inhibiting neuroinflammation, and improving cognitive impairment in hTau mice. Interestingly, chloroquine, an autophagy inhibitor, had a significant impact on total and Sarkosyl fractions of autophagy, demonstrating that it can interrupt autophagy. Notably, after administration of chloroquine, levels of Tau protein were significantly increased. When clemastine fumarate was co-administered with chloroquine, the protective effects were reversed, indicating that clemastine fumarate indeed triggered autophagy and promoted the degradation of Tau protein, while also inhibiting further Tauopathy-related neuroinflammation and synapse loss to improve cognitive function in hTau mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Neurology, Wuhan Fourth Hospital, Wuhan 430033 Hubei, China.
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Neurology, Wuhan Fourth Hospital, Wuhan 430033 Hubei, China.
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: gangli2008@hust.edu.cn.
- Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: marong1109@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, J., Jiang, X., Chang, Y., Wu, Y., Sun, S., Wang, C., Zheng, S., Wang, M., Yao, Y., Li, G., & Ma, R. (2023). Clemastine fumarate attenuates tauopathy and meliorates cognition in hTau mice via autophagy enhancement. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110649
Vancouver
Zhu J, Jiang X, Chang Y, Wu Y, Sun S, Wang C, et al. Clemastine fumarate attenuates tauopathy and meliorates cognition in hTau mice via autophagy enhancement. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110649
BibTeX
@article{Zhu2023,
author = {Zhu, Jiahui and Jiang, Xingjun and Chang, Yanmin and Wu, Yanqing and Sun, Shangqi and Wang, Cailin and Zheng, Siyi and Wang, Min and Yao, Yi and Li, Gang and Ma, Rong},
title = {Clemastine fumarate attenuates tauopathy and meliorates cognition in hTau mice via autophagy enhancement},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110649}
}
EUVIMED